{
    "code": "02023800",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023800",
    "time": "2023-09-07 21:44:40",
    "許可證字號": "衛署藥輸字第023800號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/08\/21",
    "發證\/登錄日期": "92\/08\/21",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202380000",
    "中文品名": "多膊心注射劑50毫克\/毫升",
    "英文品名": "DOBUJECT 50MG\/ML CONCENTRATE FOR PARENTERAL INFUSION",
    "適應症": "成人  增強心肌收縮力而適用於短期治療器質性心臟病、心臟外科手術引起心肌收縮力抑制而導致之心臟代償性機能衰竭。\r\n兒童  Dobutamine可用於所有年齡的兒科患者（從新生兒到18歲患者皆可使用），能夠增強心肌收縮力，而適用於短期治療因代償失調性心衰竭、心臟外科手術、心肌病變、心原性或敗血性休克引起之心輸出量及全身血液灌注量不足。",
    "劑型": "270注射劑",
    "包裝": "5公撮\\安瓿 ，100支以下安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DOBUTAMINE HCL",
    "限制項目": "02輸　入",
    "申請商名稱": "科懋生物科技股份有限公司",
    "申請商地址": "台北市南港區園區街3號14樓之6",
    "主製造廠": [
        {
            "製造廠名稱": "BAYER SCHERING PHARMA OY",
            "製造廠廠址": "PANSIONTIE 47, 20210 TURKU, FINLAND",
            "製造廠公司地址": "",
            "製造廠國別": "FINLAND",
            "製程": "市場許可證持有者"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "BERLIMED S.A.",
            "製造廠廠址": "C\/FRANCISCO ALONSO, 7 POLIGONO INDUSTRIAL SANTA ROSA 28806 ALCALA DE HENARES (MADRID), SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": ""
        },
        {
            "製造廠名稱": "PRIMEX PHARMACEUTICALS OY",
            "製造廠廠址": "MARIANKATU 21C , 00170 HELSINKI, FINLAND",
            "製造廠公司地址": "",
            "製造廠國別": "FINLAND",
            "製程": "市場許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2404300210",
            "成分名稱": "DOBUTAMINE HCL",
            "含量描述": "",
            "含量": "56.0500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "多膊心注射劑 中文仿單-106-05-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023800&Seq=003&Type=9"
        },
        {
            "title": "多膊心注射劑 英文標籤-106-05-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023800&Seq=003&Type=8"
        },
        {
            "title": "多膊心注射劑 外盒-106-05-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023800&Seq=002&Type=8"
        },
        {
            "title": "多膊心注射劑 中文標籤-106-05-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023800&Seq=001&Type=8"
        }
    ]
}